Related Experiment Videos
[Management of diabetic vasculopathy]
1Service d'Endocrinologie et de Diabétologie, Clinique Marc Linquette CHRU, Lille, France.
Therapie
|March 21, 1998
Summary
Diabetic patients face high mortality from atherothrombotic cardiovascular disease. Early screening and prevention strategies for diabetic vascular risk are crucial to reduce thrombotic events.
Area of Science:
- Cardiovascular Medicine
- Endocrinology
- Pathophysiology
Context:
- Diabetic patients exhibit a high mortality rate primarily due to atherothrombotic cardiovascular disease.
- Key contributing factors include hyperinsulinemia, insulin resistance, dyslipidemia, chronic hyperglycemia, impaired endothelial and immune cell function, and hypercoagulability.
Purpose:
- To elucidate the multifaceted pathogenesis of atherothrombotic disease in diabetes.
- To outline the clinical manifestations and common characteristics of this condition.
- To emphasize the importance of therapeutic strategies focused on screening and prevention.
Summary:
- Diabetic atherothrombotic disease manifests clinically as coronary, peripheral, and cerebral vascular insufficiency, alongside reno-vascular hypertension.
- Hallmarks include a prolonged latent period, frequent acute complications, and widespread distal vascular issues.
- The pathogenesis involves metabolic dysregulation and pro-thrombotic states.
Impact:
- Improved understanding of diabetic atherothrombotic disease pathogenesis.
- Highlights the need for codified therapeutic strategies including screening and prevention.
- Evaluating diabetic vascular risk can significantly decrease thrombotic event prevalence.